NovoCure Ltd(NVCR)Stock Analysis

Quirks, history, and lore behind NVCR — the kind of stuff that makes a stock memorable.

• 1
  The Basics

  An Israeli-American medical technology company · listed on Nasdaq · focused on treating solid tumor cancers with a decidedly non-pharmaceutical approach.
• 2
  The Numbers

  Annual revenue in the range of $500–600 million · a relatively small but growing mid-cap · with most of its sales coming from device rentals rather than one-time purchases.
• 3
  The History

  Founded in the early 2000s by Israeli physicist Yoram Palti, who spent decades studying how electric fields affect dividing cells before turning that curiosity into a cancer therapy.
• 4
  The Secret

  Its technology — called Tumor Treating Fields — uses alternating electric fields to physically disrupt cancer cell division, a mechanism unlike any chemotherapy or radiation on the market.
• 5
  The Lore

  Its flagship device, worn like a portable vest with electrode arrays, was initially met with deep skepticism from oncologists — until clinical trials in glioblastoma, one of the deadliest brain cancers, showed meaningful survival gains.
• 6
  The Giveaway

  The company's Optune device patches electrodes directly to a patient's shaved scalp and hums along 18 hours a day — zapping brain tumors with electric fields while patients go about their lives.